Jupiter Asset Management Ltd. Has $3.67 Million Holdings in Alignment Healthcare, Inc. $ALHC

Jupiter Asset Management Ltd. boosted its position in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 20.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 210,170 shares of the company’s stock after buying an additional 36,086 shares during the period. Jupiter Asset Management Ltd. owned approximately 0.11% of Alignment Healthcare worth $3,667,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. SBI Securities Co. Ltd. raised its position in shares of Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after acquiring an additional 2,970 shares in the last quarter. KBC Group NV acquired a new stake in Alignment Healthcare during the second quarter worth approximately $44,000. Wilmington Savings Fund Society FSB bought a new stake in Alignment Healthcare in the third quarter worth approximately $53,000. PNC Financial Services Group Inc. lifted its stake in Alignment Healthcare by 205.6% in the third quarter. PNC Financial Services Group Inc. now owns 3,459 shares of the company’s stock valued at $60,000 after buying an additional 2,327 shares during the period. Finally, Ameritas Investment Partners Inc. boosted its holdings in shares of Alignment Healthcare by 32.9% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock worth $182,000 after buying an additional 3,225 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Stock Down 1.2%

Alignment Healthcare stock opened at $20.60 on Friday. The firm has a market capitalization of $4.12 billion, a price-to-earnings ratio of -171.67, a price-to-earnings-growth ratio of 5.25 and a beta of 1.16. The firm’s fifty day moving average price is $21.03 and its two-hundred day moving average price is $18.35. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $23.87. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 605,648 shares of Alignment Healthcare stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $18.74, for a total transaction of $11,349,843.52. Following the completion of the transaction, the chief executive officer owned 2,234,294 shares in the company, valued at approximately $41,870,669.56. The trade was a 21.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Dawn Christine Maroney sold 282,070 shares of the stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $18.74, for a total value of $5,285,991.80. Following the completion of the sale, the president directly owned 1,385,167 shares of the company’s stock, valued at approximately $25,958,029.58. This trade represents a 16.92% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 2,150,938 shares of company stock valued at $42,274,570. 7.00% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. UBS Group lifted their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, January 14th. Barclays upped their price objective on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, October 31st. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. Finally, TD Cowen boosted their target price on Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a research report on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $23.32.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.